Immunologic Deficiency Syndromes
|
0.110 |
Biomarker
|
group |
HPO |
|
|
|
Pulmonary Fibrosis
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Hepatomegaly
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Biliary cirrhosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Malabsorption Syndrome
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Exocrine pancreatic insufficiency
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Malabsorption, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Malabsorption
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Recurrent respiratory infections
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Decreased antibody level in blood
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cholangiocarcinoma
|
0.120 |
AlteredExpression
|
disease |
BEFREE |
Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.
|
2574140 |
1989 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
High levels of p62 c-myc were associated with well differentiated tumours.
|
2679850 |
1989 |
Liver carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Most HCCs showed enhanced ras p21 and myc p62 expression, as indicated by staining intensity.
|
2548435 |
1989 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
By dividing patients into 2 levels of tumor expression of p62 c-myc, there was a trend for improved survival in patients with low expression (chi 2(1) = 3.65, p = 0.056).
|
2200214 |
1990 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Immunohistochemically, c-myc p62 positive tumor cells were found in 24 cases (46.2%), while the stromal cells around the tumor cells showed c-myc p62 immunoreactivity in all cases (100%).
|
2188234 |
1990 |
Tumor Cell Invasion
|
0.080 |
Biomarker
|
phenotype |
BEFREE |
The expression of c-myc gene and c-myc P62 protein did not correlate with histological type, depth of tumor invasion and stage grouping.
|
2188234 |
1990 |
Colorectal Carcinoma
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Comparison of deoxyribonucleic acid ploidy and nuclear expressed p62 c-myc oncogene in the prognosis of colorectal cancer.
|
2200214 |
1990 |
Malignant neoplasm of colon and/or rectum
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Comparison of deoxyribonucleic acid ploidy and nuclear expressed p62 c-myc oncogene in the prognosis of colorectal cancer.
|
2200214 |
1990 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Correlation of quantitative dot blotting of tumour mRNA to flow cytometric p62 c-myc expression was good (r = 0.87, P less than 0.01).
|
1874294 |
1991 |
Colorectal Carcinoma
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Use of the OM-11-906 monoclonal antibody for determining p62 c-myc expression by flow cytometry in relation to prognosis in colorectal cancer.
|
1874294 |
1991 |
Malignant neoplasm of colon and/or rectum
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Use of the OM-11-906 monoclonal antibody for determining p62 c-myc expression by flow cytometry in relation to prognosis in colorectal cancer.
|
1874294 |
1991 |
Colorectal Carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
DNA ploidy, c-myc oncoprotein p62 and v-H-ras oncoprotein p21 in colorectal carcinoma.
|
8461612 |
1993 |
Squamous cell carcinoma
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Alterations in exon 1 of c-myc occur in a minority of cervical cancers and there was increased expression of p62 in a cohort of HPV positive and negative cervical squamous cell carcinomas.
|
9462237 |
1997 |
cervical cancer
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Alterations in exon 1 of c-myc occur in a minority of cervical cancers and there was increased expression of p62 in a cohort of HPV positive and negative cervical squamous cell carcinomas.
|
9462237 |
1997 |
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The homologous proteins are: KH domain-containing protein overexpressed in cancer (Koc); zipcode binding protein, a protein which binds to a conserved nucleotide element in chicken beta-actin mRNA (ZBP1); and a protein which binds to a promoter cis element in Xenopus laevis TFIIIA gene (B3). p62 protein is cytoplasmic in location, and autoantibodies were found in 21% of a cohort of HCC patients.
|
10190901 |
1999 |